REMUS
Start SIP
Invest Now
Start SIP in REMUS
Remus Pharmaceuticals live price: ₹605.8. It opened at ₹596 vs previous close ₹583; intraday high/low: ₹617/₹596. The 50 & 200 DMA stand at ₹673.14/₹784.89.
Remus Pharmaceuticals Performance
- Low
- ₹596
- High
- ₹617
- 52 Week Low
- ₹580
- 52 Week High
- ₹1,145
- Open Price₹596
- Previous Close₹583
- Volume9,600
- 50 DMA₹673.14
- 100 DMA₹710.87
- 200 DMA₹784.89
Investment Returns
- Over 1 Month -14.32%
- Over 3 Month -10.64%
- Over 6 Month -26.83%
- Over 1 Year -35.72%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 24.6
- PEG Ratio
- -
- Market Cap Cr
- 714
- P/B Ratio
- 2.3
- Average True Range
- 33.32
- EPS
- 24.53
- Dividend Yield
- 0.2
- MACD Signal
- -14.07
- RSI
- 40.04
- MFI
- 53.92
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹605.80
+
22.95
(3.94%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹645.86
- 50 Day
- ₹673.14
- 100 Day
- ₹710.87
- 200 Day
- ₹784.89
Resistance and Support
606.23
- R3 637.67
- R2 627.33
- R1 616.57
- S1 595.47
- S2 585.13
- S3 574.37
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹605 As on 10 March, 2026 | 20:48
The Market Cap of Remus Pharmaceuticals is ₹713.9 Cr As on 10 March, 2026 | 20:48
The P/E ratio of Remus Pharmaceuticals is 24.6 As on 10 March, 2026 | 20:48
The PB ratio of Remus Pharmaceuticals is 2.3 As on 10 March, 2026 | 20:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.